Gene	Drug	Classification	Disease	Response
TP53	venetoclax	BCL2-inhibitor	Haem.Malignancy	Responsive
TP53	venetoclax	BCL2-inhibitor	Haem.Malignancy	Responsive
TP53	zanubrutinib	Kinase inhibitor	Haem.Malignancy	Responsive
TP53	pirtobrutinib	Kinase inhibitor	Haem.Malignancy	Responsive
TP53	venetoclax	BCL2-inhibitor	Haem.Malignancy	Responsive
TP53	olaparib	PARP inhibitor	OC	Responsive
TP53	lapatinib	TK inhibitor	OC	Resistant
TP53	doxorubicin	Chemotherapy	BC	Resistant
TP53	doxorubicin	Chemotherapy	BC	Sensitive
TP53	Fluorouracil and mitomycin C	Chemotherapy	BC	Resistant
PIK3CA	alpelisib	PI3K inhibitor	BC	Responsive
PIK3CA	capivasertib	AKT inhibitor	BC	Responsive
PIK3CA	alpelisib	PI3K inhibitor	BC	Responsive
PIK3CA	capivasertib	AKT inhibitor	BC	Responsive
PIK3CA	alpelisib	PI3K inhibitor	BC	Responsive
PIK3CA	trastuzumab	Monoclonal antibody	BC	Resistant
PIK3CA	pertuzumab	Monoclonal antibody	BC	Resistant
PIK3CA	lapatinib	TK inhibitor	BC	Resistant
PIK3CA	fulvestrant	Endocrine therapy	BC	Resistant
PIK3CA	epirubicin	Chemotherapy	BC	Resistant
PIK3CA	panitumumab	Monoclonal antibody	mCRC	Resistant
PIK3CA	cetuximab	Monoclonal antibody	mCRC	Resistant
PTEN	capivasertib	AKT inhibitor	BC	Responsive
PTEN	capivasertib	AKT inhibitor	BC	Responsive